J.R. Lillehaug

1.4k total citations
27 papers, 1.2k citations indexed

About

J.R. Lillehaug is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, J.R. Lillehaug has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in J.R. Lillehaug's work include Retinoids in leukemia and cellular processes (4 papers), RNA Interference and Gene Delivery (2 papers) and Cell death mechanisms and regulation (2 papers). J.R. Lillehaug is often cited by papers focused on Retinoids in leukemia and cellular processes (4 papers), RNA Interference and Gene Delivery (2 papers) and Cell death mechanisms and regulation (2 papers). J.R. Lillehaug collaborates with scholars based in Norway, France and United Kingdom. J.R. Lillehaug's co-authors include Jan Erik Varhaug, Dagny Faksvåg Haugen, Lars A. Akslen, Arnt J. Raae, Kjell Kleppe, H. Gobind Khorana, J.H. van de Sande, P.C. Loewen, Amos Panet and Per Eystein Lønning and has published in prestigious journals such as Nucleic Acids Research, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

J.R. Lillehaug

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.R. Lillehaug Norway 17 843 423 232 174 105 27 1.2k
Heidi Wunderli Switzerland 9 721 0.9× 338 0.8× 226 1.0× 180 1.0× 98 0.9× 12 1.3k
Beryl Hartley‐Asp Sweden 24 709 0.8× 514 1.2× 425 1.8× 177 1.0× 89 0.8× 71 1.6k
Hedy Adari United States 13 644 0.8× 148 0.3× 96 0.4× 122 0.7× 189 1.8× 16 1.2k
Weiping Luo United States 18 543 0.6× 242 0.6× 117 0.5× 180 1.0× 59 0.6× 44 1.2k
Tetsuro Orita Japan 14 1.0k 1.2× 372 0.9× 107 0.5× 175 1.0× 25 0.2× 17 1.3k
Laura Rossi Italy 21 477 0.6× 216 0.5× 76 0.3× 134 0.8× 76 0.7× 39 1.1k
Michael J. Ahearn United States 16 858 1.0× 350 0.8× 128 0.6× 156 0.9× 143 1.4× 28 1.7k
Junwon Lee South Korea 20 1.4k 1.7× 769 1.8× 296 1.3× 84 0.5× 55 0.5× 52 2.0k
Giuseppe Della Porta Italy 19 778 0.9× 619 1.5× 406 1.8× 212 1.2× 60 0.6× 51 1.6k
June Escara‐Wilke United States 16 1.2k 1.4× 481 1.1× 333 1.4× 91 0.5× 47 0.4× 25 1.8k

Countries citing papers authored by J.R. Lillehaug

Since Specialization
Citations

This map shows the geographic impact of J.R. Lillehaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Lillehaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Lillehaug more than expected).

Fields of papers citing papers by J.R. Lillehaug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Lillehaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Lillehaug. The network helps show where J.R. Lillehaug may publish in the future.

Co-authorship network of co-authors of J.R. Lillehaug

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Lillehaug. A scholar is included among the top collaborators of J.R. Lillehaug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Lillehaug. J.R. Lillehaug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knappskog, Stian, Line M. Myklebust, Christian Busch, et al.. (2011). RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer. Annals of Oncology. 22(10). 2208–2215. 32 indexed citations
2.
Karlsen, Odd André, J.R. Lillehaug, & Harald B. Jensen. (2008). The presence of multiple c‐type cytochromes at the surface of the methanotrophic bacterium Methylococcus capsulatus (Bath) is regulated by copper. Molecular Microbiology. 70(1). 15–26. 19 indexed citations
3.
Arnesen, Thomas, Darina Gromyko, Frédéric Pendino, et al.. (2006). Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-α-acetyltransferase complex. Oncogene. 25(31). 4350–4360. 85 indexed citations
4.
Aarsæther, Niels, Kenneth W. Kross, John Helge Heimdal, et al.. (2002). Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncology. 39(1). 37–48. 18 indexed citations
5.
Geisler, Stephanie, Per Eystein Lønning, Turid Aas, et al.. (2001). Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.. PubMed. 61(6). 2505–12. 264 indexed citations
6.
Sandal, Tone, Åsa Rydén Ahlgren, J.R. Lillehaug, & Stein Ove Døskeland. (2001). Establishment of okadaic acid resistant cell clones using a cDNA expression library. Cell Death and Differentiation. 8(7). 754–766. 18 indexed citations
7.
Seité, Paule, Sandrine Ruchaud, Josette Hillion, et al.. (2000). Ectopic expression of Bcl-2 switches over nuclear signalling for cAMP-induced apoptosis to granulocytic differentiation. Cell Death and Differentiation. 7(11). 1081–1089. 20 indexed citations
8.
Duprez, Estelle, G Benoît, Maria Flexor, J.R. Lillehaug, & Michel Lanotte. (2000). A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities. Leukemia. 14(2). 255–261. 69 indexed citations
9.
Haugen, Dagny Faksvåg, Lars A. Akslen, Jan Erik Varhaug, & J.R. Lillehaug. (1996). Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.. PubMed. 56(6). 1184–8. 64 indexed citations
10.
11.
12.
Curtis, Lucy J., A H Wyllie, Gareth Williams, et al.. (1994). Evidence against involvement of APC mutation in papillary thyroid carcinoma. European Journal of Cancer. 30(7). 984–987. 30 indexed citations
13.
Larsen, Terje H., et al.. (1993). Inhibition and down-regulation of protein kinase C in cultured atrial myocytes: effects on distribution of specific granules and secretion of atrial natriuretic peptide. Molecular and Cellular Endocrinology. 94(2). 173–181. 2 indexed citations
14.
Haugen, Dagny Faksvåg, Lars A. Akslen, Jan Erik Varhaug, & J.R. Lillehaug. (1993). Demonstration of a TGF‐α‐EGF‐receptor autocrine loop and c‐myc protein over‐expression in papillary thyroid carcinomas. International Journal of Cancer. 55(1). 37–43. 54 indexed citations
15.
Vassbotn, Flemming S., et al.. (1992). Absence of PDGF-induced, PKC-independent c-fos expression in a chemically transformed C3H/10T1/2 cell clone. Experimental Cell Research. 202(1). 98–104. 8 indexed citations
16.
Aasland, Rein, Lars A. Akslen, Jan Erik Varhaug, & J.R. Lillehaug. (1990). Co‐expression of the genes encoding transforming growth factor‐α and its receptor in papillary carcinomas of the thyroid. International Journal of Cancer. 46(3). 382–387. 52 indexed citations
17.
Langeland, Nina, Holm Holmsen, J.R. Lillehaug, & Lars Haarr. (1987). Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. Journal of Virology. 61(11). 3388–3393. 54 indexed citations
18.
Ueland, Per Magne, H. Refsum, Rune Male, & J.R. Lillehaug. (1986). Disposition of Endogenous Homocysteine by Mouse Fibroblast C3H/10T1/2 CI 8 and the Chemically Transformed C3H/10T1/2 MCA CI 16 Cells Following Methotrexate Exposure<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 77(1). 283–9. 32 indexed citations
19.
Aarsæther, Niels, et al.. (1986). Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets. Biochemical Journal. 238(1). 159–166. 30 indexed citations
20.
Djurhuus, Rune & J.R. Lillehaug. (1982). Butylated hydroxytoluene: Tumor-promoting activity in anin vitro two-stage carcinogenesis assay. Bulletin of Environmental Contamination and Toxicology. 29(1). 115–120. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Wunderli Breakdown of academic impact, for papers by Beryl Hartley‐Asp Breakdown of academic impact, for papers by Hedy Adari Breakdown of academic impact, for papers by Weiping Luo Breakdown of academic impact, for papers by Tetsuro Orita Breakdown of academic impact, for papers by Laura Rossi Breakdown of academic impact, for papers by Michael J. Ahearn Breakdown of academic impact, for papers by Junwon Lee Breakdown of academic impact, for papers by Giuseppe Della Porta Breakdown of academic impact, for papers by June Escara‐Wilke
Rankless by CCL
2026